Related Experiment Video
Updated: Sep 28, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
A decision theoretic approach to sample size determination in clinical trials
1University Department of Statistics, 1 South Parks Road, Oxford, OX1 3TG, UK. gittins@stats.ox.ac.uk
Abstract:
In this paper, we discuss a Behavioral Bayes approach to the determination of sample size in phase III clinical trials for which the data are assumed to come from a normal distribution for which the mean and variance are both unknown. Software is described which minimizes the expected net cost as a function of the sample size, thereby establishing the optimal sample size. This methodology extends previous work by the assumption of unknown variance. Numerical examples show that the more general model can have a large effect on the optimal sample size, compared with a procedure which uses the known variance model with an estimate of the variance.
Related Concept Videos
Sample Size Calculation
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Dose Size and Dosing Frequency: Determination Methods
Clinical Trials
There are four phases in a clinical trial. A phase one...
Dosage Regimens: Partial Pharmacokinetic Parameters
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
